Detalhe da pesquisa
1.
The ZIP6/ZIP10 heteromer is essential for the zinc-mediated trigger of mitosis.
Cell Mol Life Sci
; 78(4): 1781-1798, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32797246
2.
MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer.
Br J Cancer
; 120(6): 621-632, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30783203
3.
Correction to: Heregulin ß1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.
Breast Cancer Res
; 20(1): 98, 2018 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30165904
4.
Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer.
Hum Mol Genet
; 25(15): 3269-3283, 2016 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27378691
5.
ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells.
PLoS Biol
; 13(12): e1002330, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26717410
6.
Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long-term effects based on sequential biopsies.
Int J Cancer
; 138(1): 146-59, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26178788
7.
ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer.
PLoS Biol
; 10(12): e1001461, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23300383
8.
Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro.
Breast Cancer Res
; 16(1): R12, 2014 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24457069
9.
Assessing Susceptibility to Carbon Dioxide Gas in Three Rat Strains Using the Loss of Righting Reflex.
J Am Assoc Lab Anim Sci
; 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38325835
10.
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer.
Nat Struct Mol Biol
; 31(3): 498-512, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38182927
11.
A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer.
Breast Cancer Res
; 15(2): R18, 2013 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23497452
12.
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.
Breast Cancer Res
; 15(5): R92, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24286369
13.
Use of Loss of Righting Reflex to Assess Susceptibility to Carbon Dioxide Gas in Three Mouse Strains.
J Am Assoc Lab Anim Sci
; 62(6): 553-558, 2023 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37770194
14.
Glucocorticoid induced loss of oestrogen receptor alpha gene methylation and restoration of sensitivity to fulvestrant in triple negative breast cancer.
Gene
; 851: 147022, 2023 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36347335
15.
Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II study.
Breast Cancer Res Treat
; 133(1): 237-46, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22286314
16.
A review of the biological and clinical characteristics of luminal-like oestrogen receptor-positive breast cancer.
Histopathology
; 60(6): 854-63, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21906125
17.
The importance of targeting signalling mechanisms of the SLC39A family of zinc transporters to inhibit endocrine resistant breast cancer.
Explor Target Antitumor Ther
; 3(2): 224-239, 2022 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35591900
18.
Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.
NPJ Breast Cancer
; 8(1): 57, 2022 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35501337
19.
erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.
Breast Cancer Res
; 13(5): R93, 2011 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-21939528
20.
Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin ß1.
Breast Cancer Res
; 13(2): R29, 2011 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-21396094